IOTA Pharmaceuticals

Email Usinfo@iotapharma.com

IOTA Pharmaceuticals
Fragment - based Drug Discovery
GBM Drug Bank
Glioma & Glioblastoma
WINDOW on Glioblastoma
 
 
GBM Drug Bank

IOTA has created the GBM Drug Bank to consolidate clinical and preclinical findings in GBM and make these readily accessible to the research community in a format appropriate for efficient interrogation. The GBM Drug Bank database contains entries for compounds with a reported effect in preclinical GBM models and clinical trials. GBM Drug Bank compound annotations include chemical structure, reported mode of action, and the biological context in which compounds have been evaluated. The database also contains links to other resources such as PubChem and PubMed. Currently the database contains 500 fully annotated small molecule compounds.

Explore the GBM Drug Bank here.

If you would like to learn more about the IOTA GBM Drug Bank contact us on info@iotapharma.com



RSS